Viewing Study NCT01687218


Ignite Creation Date: 2025-12-25 @ 4:49 AM
Ignite Modification Date: 2026-01-16 @ 9:29 PM
Study NCT ID: NCT01687218
Status: COMPLETED
Last Update Posted: 2021-06-24
First Post: 2012-08-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel
Sponsor: CONRAD
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: MTN-017
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View
None NIH View
None NIH View